Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.39 |
| ▸ | CA1 | P00915 | 4/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.37 |
| ▸ | Q9HBH1 | 4/20 | 0.34 | |
| ▸ | GRIK1 | P39086 | 2/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20849995 | 0.81 | CA2 (0.38) | CA2CA1MAPK1SLC1A2SLC1A1 | |
| SCHEMBL22995173 | 0.74 | CA2 (0.39) | CA2CA1MAPK1SLC1A2SLC1A1 | |
| SCHEMBL19993074 | 0.73 | GPR84 (0.48) | CA2CA1MAPK1SLC1A2SLC1A1 | |
| SCHEMBL20630182 | 0.73 | CA2 (0.50) | CA2CA1MAPK1SLC1A2SLC1A1 | |
| SCHEMBL26153449 | 0.73 | GRIK1 (0.32) | CA2SLC1A2SLC1A1GRIK1GRIK2 | |
| SCHEMBL14297651 | 0.72 | GPR84 (0.52) | CA2SLC1A2SLC1A1GRIK1GRIK2 | |
| SCHEMBL8463182 | 0.71 | CA2 (0.46) | CA2CA1MAPK1SLC1A2SLC1A1 | |
| SCHEMBL10001196 | 0.70 | CA2 (0.61) | CA2CA1MAPK1SLC1A2SLC1A1 | |
| SCHEMBL14519745 | 0.70 | CA1 (0.48) | CA2CA1MAPK1SLC1A2SLC1A1 | |
| SCHEMBL12301666 | 0.70 | CYP2C19 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021003050-A2 | CD38-BINDING AGENTS AND USES THEREOF | KLEO PHARMACEUTICALS, INC. (US) | 2021-01-07 | — | — | WO | disclosed |